# US 2014/0207214 A1 · Apparatus and methods for controlling and applying flash lamp radiation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0207214 A1
- Document ID: US20140207214A1
- Status: Published application
- Kind: A1
- Application number: 14/223,861
- Filed: 2014-03-24
- Published: 2014-07-24
- Earliest claimed: 2010-08-05
- Assignees: Allergia, Inc.
- Inventors: Richard Oberreiter; Jan Enemaerke; Denis Bouboulis
- Web page: https://patentgrep.com/patent/US20140207214A1

## CPC

- A61N 5/0603: {for treatment of body cavities}
- A61B 2090/049: {against light, e.g. laser}
- A61B 2090/065: {for measuring contact or contact pressure}
- A61N 2005/0607: {Nose}
- A61N 2005/0626: {Monitoring, verifying, controlling systems and methods}
- A61N 2005/0654: {Lamps}
- A61N 2005/0662: {Visible light}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Apparatus and methods are disclosed for treating allergic rhinitis (seasonal and perennial hay fever), by application of flash lamp radiation. The nasal cavity can be illuminated in a safe and effective manner, with non-coherent light from a flash-lamp or other suitable source. This illumination can be accomplished in any suitable manner, including by use of a handheld device. Such handheld embodiments may contain a power source (battery or AC), control circuitry, light source (flash-lamp or diode laser), lens (focusing or non-focusing), light filter, and/or fiber-optic for delivering light to the nasal cavity. Embodiments include using any suitable light energy, such as visible light in the red wavelengths with a power output of 1 to 10 Joules per cm2. The device can be pre-programmed to deliver a specified amount of light in a specified amount of time using multiple pulses (in the case of a flash lamp) or a continuous wave (in the case of a diode laser). In many useful embodiments, a rigid fiber-optic extends from the lens/light filter a length of 10 to 20 mm, although it can be any convenient and useful size and shape. Contact sensors can be arrayed on the device for various purposes, such as to restrict illumination to times when the fiber optic is inserted into the nasal cavity. This and/or other safety features can prevent the high-intensity light from being fired into open space, a person's eyes, and/or otherwise causing a potential vision or other hazard. Preferably, the device can be easily and comfortably inserted into a nostril. The fiber-optic can be angled (either in its own shape or by the user manipulating it to a convenient angle/position) so as to allow the user to easily grip the device and insert the fiber-optic without having to use a mirror or other aid. Light from the device can be emitted at a specified light frequency that causes a desired immunosuppressive response in the cellular system.

## Claims

### Claim 1

(canceled)

### Claim 2

(canceled)

### Claim 3

(canceled)

### Claim 4

(canceled)

### Claim 5

(canceled)

### Claim 6

(canceled)

### Claim 7

(canceled)

### Claim 8

A method for narrow-band spectrum treatment of nasal membrane inflammation due to seasonal rhinosinusitis, including the steps of:
providing a handheld narrow-band light emitting device;
inserting a distal portion of that device into a subject's nostrils and positioning that distal portion within effective treatment range of the inflamed tissue in the mucosal membrane lining the subject's nasal passage way;
emitting from that distal portion a series of non-thermal narrow-bandwidth light pulses in the micro-second regime so that the pulsed light illuminates the nasal passageways, without the use of photo-sensitizing agent or other topical agent or heat targeting of bacterial growth.

### Claim 9

A method of low level light therapy to treat nasal membrane inflammation due to seasonal rhinosinusitis, including the steps of:
promoting a tissue anti-inflamatory response in the inflamed nasal tissue by causing a photo-biostimulation effect solely via a sequential series of narrow-band non-thermal flash lamp emissions from a device inserted into the subject's nasal passageways, without the use of photo-sensitizing agent or other topical agent and without applying heat to target bacterial growth.

### Claim 10

A method of treating seasonal rhinosinusitis including the steps of:
applying phototherapy and/or photo-biomodulation to a subject's inflamed nasal tissue, the application step including generating and applying visible spectrum light into a user's nasal cavity via an elongated fiber optic element by (a) inserting at least a portion of that optic element into the nasal cavity and (b) administering through that fiber optic element a dosage of approximately 1 to 10 Joules/cm2 of light energy to the user's nasal cavity.

### Claim 11 (depends on 8, 9, 10)

The method of claim 8 or claim 9 or claim 10, in which the generated visible spectrum light or light pulses is/are in the wavelength of approximately 600 nm to 700 nm.

### Claim 12 (depends on 8, 9, 10)

The method of claim 8 or claim 9 or claim 10, in which the generated visible spectrum light or light pulses is/are in the wavelength of approximately 600 nm to 990 nm.

### Claim 13 (depends on 8, 9, 10)

The method of claim 8 or claim 9 or claim 10, in which the generated visible spectrum light or light pulses is/are a series of micro-second pulsewidths of light, in the range of 10-100 microseconds.

### Claim 14 (depends on 8, 9, 10)

The method of claim 8 or claim 9 or claim 10, including the step of repeating the treatment more frequently than once a day.

### Claim 15 (depends on 8, 9, 10)

The method of claim 8 or claim 9 or claim 10, in which the generated visible spectrum light or light pulses delivers, at a distance of approximately 25 mm from a distal exit of the device approximately 0.1 J/cm2 per pulse.

### Claim 16 (depends on 15)

The method of claim 15, including the step of applying approximately 12 pulses within a single treatment cycle for the subject.
